Bradley J. Bolzon Ph.D. is Director at CRISPR Therapeutics AG (CRSP). They have made 44 open-market trades across 5 companies since 2007, most recently 2021-07-19.
CIK 0001354345
5 open-market purchases totalling $27.3M since 2007, against 39 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 47% | 47% | 80% |
| Avg Move | +1.3% | +7.0% | -2.2% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | SELL | 2021-07-19 | 2021-07-21 | $126.36 | $2.4M | -5.9% | -9.9% | -22.9% |
| CRSP | SELL | 2021-06-29 | 2021-06-30 | $149.51 | $14.1M | -15.9% | -24.9% | -30.4% |
| CRSP | SELL | 2021-06-28 | 2021-06-30 | $152.44 | $9.2M | -15.9% | -24.9% | -30.4% |
| GLUE | BUY | 2021-06-28 | 2021-06-30 | $19.00 | $3.0M | -18.5% | +7.5% | +4.2% |
| CRSP | SELL | 2021-06-11 | 2021-06-15 | $126.43 | $2.3M | +15.5% | +3.0% | -4.4% |
| CRSP | SELL | 2021-03-22 | 2021-03-24 | $132.36 | $8.0M | +10.6% | +15.0% | +17.5% |
| CRSP | SELL | 2021-02-19 | 2021-02-23 | $149.50 | $39.4M | -16.9% | -16.9% | -16.2% |
| CRSP | SELL | 2020-12-16 | 2020-12-18 | $149.07 | $4.2M | +3.3% | +33.8% | -16.6% |
| CRSP | SELL | 2020-12-10 | 2020-12-17 | $142.87 | $7.2M | +7.5% | +32.0% | -12.7% |
| CRSP | SELL | 2020-12-07 | 2020-12-09 | $154.16 | $49.6M | +14.5% | +33.0% | -13.8% |
| BDTX | SELL | 2020-11-30 | 2020-12-01 | $33.14 | $682K | +9.0% | +0.1% | -12.8% |
| BDTX | SELL | 2020-11-19 | 2020-11-23 | $33.01 | $8.6M | -1.3% | -3.2% | -19.7% |
| BDTX | SELL | 2020-11-17 | 2020-11-19 | $33.05 | $279K | +1.4% | -4.4% | -10.9% |
| BDTX | SELL | 2020-11-13 | 2020-11-17 | $33.75 | $293K | +0.4% | -0.4% | -18.9% |
| BDTX | SELL | 2020-11-12 | 2020-11-13 | $34.13 | $991K | +0.2% | +2.8% | -16.4% |
| BDTX | SELL | 2020-11-10 | 2020-11-12 | $34.10 | $2.6M | -2.8% | -1.9% | -19.3% |
| BDTX | SELL | 2020-11-06 | 2020-11-10 | $33.08 | $586K | -1.9% | +2.0% | -14.6% |
| BDTX | SELL | 2020-11-04 | 2020-11-06 | $33.15 | $708K | -1.2% | +2.8% | -12.9% |
| BDTX | SELL | 2020-10-26 | 2020-10-28 | $33.29 | $535K | +4.6% | +12.3% | -19.8% |
| BDTX | SELL | 2020-10-15 | 2020-10-20 | $33.44 | $992K | +7.2% | +12.4% | -6.6% |
| BDTX | SELL | 2020-10-13 | 2020-10-15 | $33.29 | $1.1M | -0.0% | -0.9% | -9.1% |
| BDTX | SELL | 2020-10-08 | 2020-10-13 | $33.50 | $1.4M | -4.9% | +2.4% | +3.7% |
| BDTX | SELL | 2020-10-06 | 2020-10-08 | $33.44 | $3.1M | -11.7% | -3.9% | -0.4% |
| CRSP | SELL | 2020-09-18 | 2020-09-22 | $86.87 | $527K | -10.2% | +1.7% | +88.1% |
| CRSP | SELL | 2020-09-16 | 2020-09-18 | $86.98 | $1.6M | -1.4% | +27.0% | +75.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.